Ironwood Pharmaceuticals (IRWD) Reports Q1 Loss, Misses Revenue Estimates

Ironwood Pharmaceuticals (IRWD) came out with a quarterly loss of $0.14 per share versus the Zacks Consensus Estimate of a loss of$ 0.05. This compares to loss of $0.02 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -180%. A quarter ago, it was expected that this drugmaker would post earnings of$ 0.10 per share when it actually produced earnings of $0.02, delivering a surprise of -80%.Over the last four quarters, the company ...